COMP <GO>
ATNM vs ELTX // GROSS PROFIT MARGIN
Actinium Pharmaceuticals Inc. (Delaware) (NYSE) VS. Elicio Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ATNM 2
— ELTX 0
■ METRIC PARITY
LAST: $1.53 (+10.87%) • MKT CAP: $48.1M
gross-margins
—
LAST: $1.75 (-5.40%) • MKT CAP: $47.4M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ATNM VS. ELTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ATNM | ELTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.1 | 45.0 | +18.10 | ATNM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $48.1M | $47.4M | $695.8K | ATNM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ATNM REV | ELTX REV | ATNM GROSS % | ELTX GROSS % | ATNM FCF | ELTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $90.0K | $0 | — | — | -$24.7M | -$37.0M |
| FY 2024 | $0 | $0 | — | — | -$33.1M | -$37.2M |
| FY 2023 | $81.0K | $0 | — | — | -$47.3M | -$32.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ATNM // BETA —
ELTX // BETA —